Brian I. Carr, MD, PhD, FRCP (Curriculum Vitae)

Brian I. Carr, MD, PhD, FRCP, is director of the Liver Tumor Program of Thomas Jefferson University Hospital’s Kimmel Cancer Center and professor of medicine at Thomas Jefferson University. He is a leading expert in the treatment of primary liver cancer.

Dr. Carr received his medical education at the University of London and his doctorate of philosophy degree in molecular biology in the laboratory of Nobel Laureate Renato Dulbecco. He completed a medical oncology fellowship at the Royal Marsden Hospital, London, UK and the Royal Post-Graduate Medical School, London, UK. He then moved to the United States in 1977, where he repeated a medical oncology fellowship at the University of Wisconsin. After 10 years as a staff physician, assistant professor and then as an associate professor at the City of Hope Medical Program in Duarte, California, he moved to Pittsburgh, where he served as director of the Liver Cancer Program of UPMC Cancer Centers and professor of medicine at the University of Pittsburgh.

His main areas of work have been in growth factors, particularly growth inhibitors for liver regeneration and liver carcinogenesis. In recent years, he has worked on developing a novel family of growth inhibitors based upon the vitamin K structure. He has also become an expert in the management of advanced stage HCC and has the largest experience in North America of the intrahepatic chemoembolization for HCC. Dr. Carr has 200 published papers and more than 300 published abstracts in these areas.